Pathogen Inhibition
Pathogen Inhibition - Related Videos
00:46
Feedback Inhibition
0 Views •
2019
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell! Since enzymes help control the rate of reactions, their activity is regulated so that appropriate amounts of starting materials, intermediate metabolites, and products are maintained in the cell. Excessive build-up or depletion of...
02:29
Measuring Immune-Induced Inhibition of Seedling Growth
0 Views •
2025
This video demonstrates the seedling growth inhibition assay in the Arabidopsis thaliana plant. The impact of increased concentration of immune peptide elicitor on seedling growth is determined.
10:39
Single Cell Measurements of Vacuolar Rupture Caused by Intracellular Pathogens
0 Views •
Cited by 22 •
2013
We describe a method for tracking the endomembrane rupture elicited by the intracellular bacteria Shigella flexneri and Mycobacterium tuberculosis upon host cell invasion. Our assay makes use of CCF4, a host cytoplasmic FRET probe in live or fixed cells. This reporter is degraded by an enzyme activity present on the bacterial surface.
01:30
Enzyme Inhibition
0 Views •
2025
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure. Competitive inhibitors occupy the active site of enzymes, making them unable to accommodate the substrate. However, sufficiently high...
01:31
Determining the Minimum Inhibitory Concentration of Enrofloxacin Against Avian Pathogenic E. coli
0 Views •
2026
Begin with a suspension of avian pathogenic E. coli or APEC in growth media.APEC is a Gram-negative bacterium that infects poultry by entering through the respiratory tract.After breaching the mucosal layer, APEC adhere to epithelial cells, multiply locally, and disrupt the epithelial barrier to enter the bloodstream. The bacteria then spread to multiple organs, causing systemic infection.Add an equal volume of the bacterial suspension to each well of a multi-well plate containing increasing...
FAQs
Physical barriers and immune defenses provide complementary layers of protection against infection. Barriers can prevent microorganisms from entering or reaching suitable tissues, while immune defenses act against organisms that overcome those barriers. Examining both layers helps biologists analyze host–microbe interactions and determine how suppression of pathogen activity contributes to preventing infection from becoming established.
Several essential processes can be targeted, including cell-wall formation, protein synthesis, metabolism, and genome replication. Interfering with these functions can restrict growth or replication and may prevent a microorganism from maintaining activity in a host or environment. Identifying the affected process helps researchers explain how an antimicrobial compound or therapeutic agent produces its inhibitory effect.
Suppression and killing represent different outcomes. An inhibitory intervention may slow growth, limit replication, or reduce the ability to establish infection while leaving some organisms viable. This distinction matters when interpreting antimicrobial results, because reduced activity does not necessarily demonstrate elimination. Biology research therefore considers whether an intervention limits pathogen behavior, destroys the organism, or produces another measurable effect.
Researchers can compare interventions by examining which essential pathogen process they disrupt and what biological outcome follows. One approach may affect cell-wall formation, whereas another may interfere with protein synthesis, metabolism, or genome replication. Linking the target process with changes in growth, replication, or infection establishment helps distinguish mechanisms and supports evaluation of antimicrobial efficacy.
Evaluation focuses on whether an antimicrobial compound or therapeutic agent produces a measurable reduction in pathogen growth, replication, activity, or ability to establish infection. Researchers also consider the mechanism being disrupted and whether the outcome reflects inhibition rather than killing. Such comparisons provide evidence for judging efficacy and for investigating why resistance may affect treatment performance.
In host–microbe studies, researchers examine how physical barriers, immune defenses, antimicrobial compounds, and therapeutic agents influence the relationship between an organism and its host. They assess whether pathogen activity is limited and whether infection can become established. These observations clarify protective biology and help connect inhibitory mechanisms with disease prevention and treatment strategies.
The principles extend across biotechnology, food safety, agriculture, and public health. In each setting, the goal is to limit undesirable microbial growth, replication, activity, or infection establishment using relevant biological or antimicrobial strategies. Studying these applications also supports broader efforts to control disease-causing microorganisms and evaluate how interventions perform in different biological and practical contexts.
Resistance is important because it can influence how effectively an antimicrobial compound or therapeutic agent suppresses a pathogen. Studying inhibition alongside resistance allows researchers to evaluate not only whether activity decreases, but also how microbial characteristics may affect that outcome. This context supports the development and assessment of strategies for disease prevention and treatment.